Indeed there are a significant number of pathological mutations at the 3′ end of human FGB[49], and thus the incorporation of fibrinogen containing Fgb-eGFP into the crosslinked fibrin mesh may be simulating dys- or afibrinogenemia. Here, FGB is linked to congenital afibrinogenemia.